Methylphenidate Hydrochloride Tablets Recalled Due to Metal Contamination
Sun Pharmaceutical Industries is recalling 7,313 bottles of Methylphenidate Hydrochloride Tablets (20mg) due to metal embedded in some tablets. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with a physical contamination hazard (metal embedded in tablets). Although no illnesses or injuries have been reported, the presence of metal in tablets represents a risk-of-harm product meeting the criteria for Score 3.
Plain-English summary
Sun Pharmaceutical Industries Inc. is recalling 7,313 bottles of Methylphenidate Hydrochloride Tablets, USP 20mg (Lot AC74459, expiration 07/31/2024). The tablets are manufactured by Ohm Laboratories Inc., New Brunswick, NJ, and distributed by Sun Pharmaceutical Industries Inc., Cranbury, NJ.
The recall was initiated due to the presence of metal embedded in some tablets. The product was distributed nationwide.
Patients currently taking this medication should not use tablets from the recalled lot and should consult their healthcare provider. The affected package NDC numbers include 57664-228, 57664-229, and 57664-230.
The recalled product
- Product
- METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug
- Affected units
- 7,313
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot AC74459
- Exp 07/31/2024
UPCs (3)
- 0357664228883
- 0357664229880
- 0357664230886
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METHYLPHENIDATE HYDROCHLORIDE
- HighMethylphenidate Hydrochloride Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2024-07-10
- ModerateMethylphenidate Hydrochloride Chewable Tablets Recalled for Failed Specifications
FDA (Drugs) · 2022-03-02
- ModerateTeva Recalls Methylphenidate Hydrochloride Extended-Release Tablets Due to Missing Desiccant
FDA (Drugs) · 2020-02-19
- ModerateTeva Recalls Methylphenidate Hydrochloride Extended-Release Tablets Due to Missing Desiccant
FDA (Drugs) · 2020-02-19
- ModerateOsmotica Recalls Subpotent Methylphenidate Hydrochloride Extended-Release Tablets
FDA (Drugs) · 2018-03-14
Same manufacturer · SUN PHARMACEUTICAL INDUSTRIES INC
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · metal contamination
See all →- HighRose and Shore Margarita Thin Crust Pizza Recalled for Metal Contamination
FDA (Food) · 2026-04-01
- HighWhite Oak Pastures Ground Beef Alerted for Possible Metal Contamination
USDA FSIS · 2026-03-23
- HighTestosterone 200 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone 87.5 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone and triamcinolone pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05